Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

KURA – Kura Oncology, Inc.

KURA — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

17.91

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

-0.1

EPS Last/This Y

-0.34

EPS This/Next Y

0.97

Price

11.22

Target Price

31.17

Analyst Recom

1.2

Performance Q

34.73

Upside

-1,142.2%

Beta

0.36

Ticker: KURA




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-24KURA9.270.250.154993
2026-04-27KURA9.080.240.365932
2026-04-28KURA8.840.240.126076
2026-04-29KURA8.760.247.556211
2026-04-30KURA8.850.310.916535
2026-05-01KURA8.780.311.716552
2026-05-04KURA9.240.310.036568
2026-05-05KURA9.30.290.607031
2026-05-06KURA9.560.290.237118
2026-05-07KURA9.350.290.087122
2026-05-08KURA9.420.290.097113
2026-05-11KURA9.520.280.107342
2026-05-12KURA9.660.270.037466
2026-05-13KURA9.490.270.067626
2026-05-14KURA9.750.260.047660
2026-05-15KURA9.230.260.327696
2026-05-18KURA9.210.200.924244
2026-05-19KURA8.940.230.094402
2026-05-20KURA10.340.170.015502
2026-05-21KURA11.140.110.077824
2026-05-22KURA11.220.080.0811406
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-24KURA9.27-17.5-41.9-3.43
2026-04-27KURA9.08-17.5-14.0-3.43
2026-04-28KURA8.84-17.5-4.8-3.43
2026-04-30KURA8.83-17.5-60.7-3.43
2026-05-01KURA8.77-17.5-32.4-3.43
2026-05-04KURA9.25-17.5-149.7-3.43
2026-05-05KURA9.28-17.5-51.9-3.43
2026-05-06KURA9.56-17.5-91.1-3.43
2026-05-07KURA9.35-17.5-14.8-3.43
2026-05-08KURA9.42-17.5-58.7-3.43
2026-05-11KURA9.51-17.5-59.5-3.43
2026-05-12KURA9.66-17.5-66.1-3.43
2026-05-13KURA9.48-17.5-18.8-3.43
2026-05-14KURA9.76-17.5-55.7-3.43
2026-05-15KURA9.22-17.53.8-3.43
2026-05-18KURA9.21-17.5-47.0-3.51
2026-05-19KURA8.95-17.5-18.1-3.51
2026-05-20KURA10.33-17.5-223.6-3.52
2026-05-21KURA11.14-17.5-114.3-3.52
2026-05-22KURA11.22-20.8-54.8-3.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-24KURA-4.091.2316.58
2026-04-27KURA-4.07-0.2117.44
2026-04-28KURA-4.07-0.2117.44
2026-04-29KURA-4.07-0.2117.44
2026-04-30KURA-4.07-0.2117.44
2026-05-01KURA-4.07-0.2117.44
2026-05-04KURA-4.070.0917.35
2026-05-05KURA-4.870.0917.35
2026-05-06KURA-4.870.0917.35
2026-05-07KURA-4.870.0917.35
2026-05-08KURA-4.870.0917.35
2026-05-11KURA-4.87-1.2617.35
2026-05-12KURA-4.87-1.2617.84
2026-05-13KURA-4.87-1.2617.84
2026-05-14KURA-4.87-1.2617.84
2026-05-15KURA-3.03-1.2617.83
2026-05-18KURA-3.03-0.9817.83
2026-05-19KURA-3.04-0.9817.91
2026-05-20KURA-2.58-0.9817.91
2026-05-21KURA-2.75-0.9817.91
2026-05-22KURA-2.75-0.9817.91
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.83

Avg. EPS Est. Current Quarter

-0.91

Avg. EPS Est. Next Quarter

-0.93

Insider Transactions

-2.75

Institutional Transactions

-0.98

Beta

0.36

Average Sales Estimate Current Quarter

19

Average Sales Estimate Next Quarter

22

Fair Value

Quality Score

36

Growth Score

27

Sentiment Score

97

Actual DrawDown %

53.9

Max Drawdown 5-Year %

-76.5

Target Price

31.17

P/E

Forward P/E

PEG

P/S

13.94

P/B

9.26

P/Free Cash Flow

EPS

-3.35

Average EPS Est. Cur. Y​

-3.52

EPS Next Y. (Est.)

-2.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-411.19

Relative Volume

1.59

Return on Equity vs Sector %

-300.1

Return on Equity vs Industry %

-284.5

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.17

EBIT Estimation

-54.8
KURA Healthcare
$11.25
📉
Swing / Pullback
Buy the dip on strong trends
43 /100
WEAK
Trend
20/20
Pullback
4/25
Volume
0/15
Valuation
9/20
TP/AR
2/10
Options
8/10
RSI
71.5
Range 1M
89%
Sup Dist
7.6%
🚀
Momentum Growth
Ride accelerating trends
48 /100
WEAK
Momentum
19/25
Growth
14/30
Estimates
0/20
Inst/Vol
7/15
Options
8/10
EPS Yr
-11.5%
EPS NY
25.5%
52W%
81.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +177.1% upside
Quality
7/30
Valuation
15/30
Growth
10/25
Stability
7/10
LT Trend
4/5
Upside
+177.1%
Quality
36
Kura Oncology, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA

Latest News

Caricamento notizie per KURA
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading